Clinical course and prognostic factors following bone recurrence from breast cancer
Open Access
- 1 January 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 77 (2), 336-340
- https://doi.org/10.1038/bjc.1998.52
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Use of bisphosphonates in cancer patientsCancer Treatment Reviews, 1996
- Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatmentCancer Treatment Reviews, 1996
- Localization of parathyroid hormone-related protein mrna expression in breast cancer and metastatic lesions by in situ hybridizationJournal of Bone and Mineral Research, 1992
- Parathyroid hormone related protein and skeletal morbidity in breast cancerEuropean Journal Of Cancer, 1992
- Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasisBreast Cancer Research and Treatment, 1991
- Bone metastases: Pathogenesis, treatment, and rationale for use of resorption inhibitorsAmerican Journal Of Medicine, 1987
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957